Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): Rationale and Design of a Multicenter, Cross-sectional Study

NCT04019600 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04019600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04019600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): Rationale and Design of a Multicenter, Cross-sectional Study
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Suspended
Start date
December 23, 2019
Completion date
December 22, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, pulmonary hypertension